Chronic pancreatitis does not cause adverse effect in fetus, mother: Study

Medically Reviewed By : Dr. Kamal Kant Kohli

Published On 2020-12-24 10:45 GMT | Update On 2020-12-25 07:44 GMT

New Delhi, India: Chronic pancreatitis (CP) is not associated with increased risk of adverse maternal and fetal outcomes during pregnancy, suggests a recent study in the American Journal of Gastroenterology. According to the AIIMS researchers, CP in younger patients results in later and fewer pregnancies, however, there was no increased risk of adverse outcomes in baby and the mother.

There are limited data on the effect of chronic pancreatitis on pregnancy outcomes and vice versa. Pramod Kumar Garg, All India Institute of Medical Sciences, New Delhi, India, and colleagues aimed to evaluate the clinical trajectory of CP during pregnancy and its effect on pregnancy outcomes.

The researchers studied all female patients of child-bearing age (≥15 years) diagnosed with CP from January 2004 to July 2019. They assessed the change in frequency of painful episodes before, during, and after pregnancy. Maternal and fetal outcomes were compared between pregnant women (early onset) and women presenting with CP after completion of all pregnancies (late onset). Of 187 women with CP, pregnancy outcomes and clinical course were assessed in 99 patients.

Key findings of the study include:

The frequency of painful exacerbations was significantly lower during pregnancy compared with prepregnancy and postpregnancy periods.
The median pain score decreased significantly to 0 during pregnancy from 3 before conception and increased to 4 after pregnancy.
Women with early onset CP (n = 57) had their first child later and had fewer pregnancies compared with those with late onset CP (n = 42).
There was no difference in maternal outcomes such as gestational diabetes, hypertension, and preterm delivery, and fetal outcomes such as abortion, low birth weight, and still birth between the groups.
There was no reported congenital anomaly.

"The clinical course of CP was usually benign during pregnancy with decreased frequency and severity of pain," wrote the authors.

The study, "Clinical Course of Chronic Pancreatitis During Pregnancy and its Effect on Maternal and Fetal Outcomes," is published in the journal American Journal of Gastroenterology.

DOI: https://journals.lww.com/ajg/Abstract/9000/Clinical_Course_of_Chronic_Pancreatitis_During.98997.aspx

Article Source : American Journal of Gastroenterology

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Medha Baranwal

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Chronic pancreatitis does not cause adverse effect in fetus, mother: Study

Similar News

PET/MRI Outperforms Standard Imaging in Rectal Cancer Staging, Study Shows

Preoperative Carbohydrate Loading Benefits in Liver Resection: Study

Single-Incision Laparoscopic Cholecystectomy Safe, Feasible, and Comparable to CLC: Study Shows

Peptic ulcer does not significantly increase CVD risk, finds study

Preemptive Genetic Testing Feasible for Reducing Chemotherapy Toxicity in GI Cancer, Finds Trial

Multifactorial Risk Control Lowers Liver Disease Burden in Type 2 Diabetes, Study Shows

AI analysis of colonoscopy improves assessment of Crohn's disease: Study

Tirzepatide- A novel therapeutic against metabolic dysfunction-associated steatotic liver disease, reports research